Feature|Articles|October 15, 2024
- Pharmaceutical Executive: October 2024
- Volume 44
- Issue 10
Pharmaceutical Executive: October 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive October 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 1 year ago
Assembly Required: Building Blocks in Biopharmaover 1 year ago
Pharma’s Cold Calling: CGT Space at a Critical Crossroadsover 1 year ago
‘Selling a Vision’: Today’s Playbook for Startupsover 1 year ago
Rafaat Rahmani: Beating the Oddsover 1 year ago
AI: A Value Advantage? Maximizing Your Brand Outreachover 1 year ago
How to Rally a Team Around Building a New Businessover 1 year ago
Trading Quality for Convenience? The New Tech Balancing Actover 1 year ago
Amazon Targeting the Transactional in the Pharma MarketNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
ACIP Member Claims FDA Commissioner is Halting Decision to Remove Covid Vaccines from the Market: Report
3
FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo
4
From OR to Office: How Workflow Change and AI Are Reshaping MedTech Adoption
5